Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenling Baizhu Pill (参苓白术丸) is a traditional Chinese medicine (TCM) formulation manufactured by Shandong Wohua Pharmaceutical. It is based on the classical TCM formula Shenling Baizhu San, which is traditionally used to tonify the spleen and stomach, replenish qi, and eliminate dampness. The formulation typically contains a combination of ten herbal ingredients, including Panax ginseng (Ren Shen), Poria cocos (Fu Ling), and Atractylodes macrocephala (Bai Zhu). It is primarily indicated for the treatment of spleen-stomach deficiency characterized by symptoms such as poor appetite, loose stools, diarrhea, and physical weakness. As a traditional Chinese patent medicine, it represents a complex multi-herb formulation rather than a single active ingredient small molecule drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenling Baizhu Pill.